Advances in engineered bacteria vaccines for enhancing anti-cancer immunity

被引：1
|
作者：
Liu, Wu [1 ]
Chen, Wenjing [2 ]
Cai, Yujie [2 ]
Tang, Yanhua [3 ]
Chen, Tingtao [1 ,4 ,5 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Nanchang 330008, Jiangxi, Peoples R China
[2] Nanchang Univ, Jiangxi Med Coll, Sch Pharm, Nanchang 330008, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Dept Cardiovasc Surg, 1 Minde Rd, Nanchang 330008, Jiangxi, Peoples R China
[4] Nanchang Univ, Jiangxi Med Coll, MOE Basic Res & Innovat Ctr Targeted Therapeut Sol, Sch Pharm,Jiangxi Prov Key Lab Bioengn Drugs, Nanchang 330031, Jiangxi, Peoples R China
[5] Nanchang Univ, Inst Translat Med, Jiangxi Med Coll, Natl Engn Res Ctr Bioengn Drugs & Technol, 1299 Xuefu Ave, Nanchang 330031, Jiangxi, Peoples R China
来源：
MICROBIOME RESEARCH REPORTS | 2025年 / 4卷 / 01期
关键词：
Engineered bacteria; antitumor; neoantigenic; immunotherapy;
D O I：
10.20517/mrr.2024.75
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Advances in synthetic biology have enabled the development of tumor-targeted live bacterial therapeutics. In a recent study published in Nature, Redenti et al. engineered Escherichia coli Nissle 1917(EcNc Delta lon/Delta ompT/LLO+ nAg), which exploits the advantages of living medicines to deliver arrays of tumor-specific neoantigenic epitope in optimal environments, thereby providing a novel strategy for developing effective and durable cancer immunotherapies.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Biomaterials for enhancing anti-cancer immunity
    Koshy, Sandeep T.
    Mooney, David J.
    CURRENT OPINION IN BIOTECHNOLOGY, 2016, 40 : 1 - 8
  • [2] Advances and challenges in anti-cancer vaccines for multiple myeloma
    Abdollahi, Pegah
    Norseth, Hanne Marie
    Schjesvold, Fredrik
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes
    Cheng, Qinqin
    Dai, Zhefu
    Smbatyan, Goar
    Epstein, Alan L.
    Lenz, Heinz-Josef
    Zhang, Yong
    MOLECULAR THERAPY, 2022, 30 (09) : 3066 - 3077
  • [4] ANTI-CANCER IMMUNITY
    YAMAMURA, Y
    JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, 1981, 70 (02): : 33 - 34
  • [5] Anti-cancer therapeutic vaccines
    Lantz, Olivier
    Girard, Nicolas
    Vivier, Eric
    Miossec, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (09): : 1254 - 1257
  • [6] Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?
    Iero, Manuela
    Filipazzi, Paola
    Castelli, Chiara
    Belli, Filiberto
    Valdagni, Riccardo
    Parmiani, Giorgio
    Patuzzo, Roberto
    Santinami, Mario
    Rivoltini, Licia
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (07) : 1159 - 1167
  • [7] Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?
    Manuela Iero
    Paola Filipazzi
    Chiara Castelli
    Filiberto Belli
    Riccardo Valdagni
    Giorgio Parmiani
    Roberto Patuzzo
    Mario Santinami
    Licia Rivoltini
    Cancer Immunology, Immunotherapy, 2009, 58 : 1159 - 1167
  • [8] Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines-A Narrative Review
    Kielbowski, Kajetan
    Plewa, Paulina
    Zadworny, Jan
    Bakinowska, Estera
    Becht, Rafal
    Pawlik, Andrzej
    VACCINES, 2025, 13 (03)
  • [9] Cloaked anti-cancer bacteria
    Burke, Maria
    CHEMISTRY & INDUSTRY, 2022, 86 (04) : 11 - 11
  • [10] Engineered cytokine-antibody fusion proteins for targeted stimulation of anti-cancer immunity
    Spangler, Jamie B.
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
12345